Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.
Analyst recommendations: Abbott Laboratories, Boston Scientific, Costco, Medtronic, Valero Energy...
Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
A. O. Smith Corp: Longbow Research upgrades to buy from neutral. PT up 24% to $71.
Abbott Laboratories: Wolfe Research initiated coverage with a recommendation of underperform. PT set to $95.
Avid Technology: J.P. Morgan reinstated coverage with a recommendation of overweight. PT set to $33.
Boston Scientific: Wolfe Research initiated coverage with a recommendation of outperform. PT set to $43.
Callon Petroleum: RBC Capital Markets upgrades to outperform from sector perform. PT jumps 109% to $75.
Continental Resources: RBC Capital Markets downgrades to sector perform from outperform. PT up 25% to $80.
Costco Wholesale: Evercore ISI lowers Price Target to $520 from $535, maintains Outperform rating.
Earthstone: RBC Capital Markets downgrades to sector perform from outperform. PT rises 69% to $21.
EOG Resources: RBC Capital Markets downgrades to sector perform from outperform. PT up 43% to $150.
Intertek: Jefferies downgrades from buy to hold saying GBp 4700.
Littelfuse: Baird cut the recommendation to neutral from outperform. PT up 7.2% to $269.
Medtronic: Wolfe Research initiated coverage with a recommendation of underperform. PT set to $85.
Pioneer Natural: RBC Capital Markets downgrades to sector perform from outperform. PT up 35% to $290.
Sage: Barclays moves from Underweight to Equal-Weight targeting GBp 720.
Teleflex: Wolfe Research initiated coverage with a recommendation of outperform. PT up 19% to $300.
Valero Energy: Barclays raises Price Target to $133 from $120, maintains Overweight rating.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
